Intranasal Dexmedetomidine vs Oral Midazolam for Premedication in Pediatric Surgery
NCT07565116
Summary
This study aims to compare the effects of intranasal dexmedetomidine and oral midazolam as premedication in pediatric patients undergoing elective inguinal and urological surgery under general anesthesia. Premedication plays a critical role in reducing preoperative anxiety, facilitating parent-child separation, and improving cooperation during anesthesia induction in pediatric patients. While oral midazolam is widely used, it has several limitations, including variable bioavailability and the risk of paradoxical reactions. Intranasal dexmedetomidine has emerged as a promising alternative due to its sedative, anxiolytic, and minimal respiratory depressant effects. In this prospective, randomized, double-blind, controlled study, patients aged 2-10 years will be assigned to receive either intranasal dexmedetomidine or oral midazolam prior to anesthesia induction. The primary outcome is the proportion of patients achieving adequate sedation at induction, defined as a Ramsay Sedation Score (RSS) ≥2. Secondary outcomes include perioperative hemodynamic stability, parent-child separation anxiety, mask acceptance during induction, postoperative emergence agitation, recovery time, and the need for rescue sedation.
Eligibility
Inclusion Criteria: * Pediatric patients aged 2-10 years * ASA physical status I-II * Scheduled for elective inguinal or urological surgery under general anesthesia * Both male and female patients * Written informed consent obtained from parents or legal guardians Exclusion Criteria: * Known allergy or hypersensitivity to dexmedetomidine or midazolam * Presence of significant systemic disease or organ dysfunction * Cardiac arrhythmia or congenital heart disease * Neurological or behavioral disorders, including developmental delay * Chronic use of analgesics or other medications that may affect study outcomes * Anticipated difficult airway * Nasal pathology that may interfere with intranasal drug administration * Emergency surgery * Inability to obtain written informed consent from parents or legal guardians
Conditions4
Interventions2
Related trials
- Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia — Second Affiliated Hospital of Wenzhou Medical University
- Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA — Poznan University of Medical Sciences
- Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block — Fayoum University
- Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery — University of Novi Sad
- Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect — Alexandria University
- Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient — Dharmais National Cancer Center Hospital
- Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia — University Hospital, Montpellier
- Mental Health After Dexmedetomidine for Electrical Storm — Ottawa Heart Institute Research Corporation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07565116